A study of LAG-3 as a potential immunotherapeutic target for microsatellite-stable, PD-L1+ endometrioid endometrial cancer has substantiated that LAG-3 may be a potential target for immunotherapy in this cancer [22]. Here, LAG3 is linked to cancer.